Summit Trail Advisors’s Kodiak Sciences KOD Stock Holding History

Summit Trail Advisors’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-89,308	Closed	-$616K	–	562
2023 Q2	$616K	Sell	89,308 -427	-0.5%	-$2.61K	0.02%	226
2023 Q1	$556K	Buy	89,735 +427	+0.5%	+$2.99K	0.02%	206
2022 Q4	$639K	Hold	89,308	–	–	0.03%	147
2022 Q3	$691K	Hold	89,308	–	–	0.04%	140
2022 Q2	$682K	Sell	89,308 -18,044	-17%	-$127K	0.04%	151
2022 Q1	$829K	Sell	107,352 -7	-0%	-$273	0.07%	117
2021 Q4	$9.1M	Sell	107,359 -274	-0.3%	-$27.9K	0.59%	39
2021 Q3	$10.3M	Sell	107,633 -3	-0%	-$277	0.78%	29
2021 Q2	$10M	Sell	107,636 -101	-0.1%	-$9.69K	0.88%	26
2021 Q1	$12.2M	Sell	107,737 -12,500	-10%	-$1.71M	1.32%	20
2020 Q4	$17.7M	Hold	120,237	–	–	2.23%	12
2020 Q3	$14.7M	Buy	120,237 +102,237	+568%	+$5.13M	2.85%	11
2020 Q2	$974K	Hold	18,000	–	–	0.18%	52
2020 Q1	$859K	Hold	18,000	–	–	0.23%	46
2019 Q4	$1.29M	Hold	18,000	–	–	0.75%	26
2019 Q3	$259K	Hold	18,000	–	–	0.09%	72
2019 Q2	$211K	Buy	+18,000	New	+$160K	0.09%	71

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Summit Trail Advisors's KOD Position: Q3 2023 in Review

Summit Trail Advisors sold out of Kodiak Sciences (KOD) in Q3 2023, closing a stake of 89,308 shares — an estimated $616K sold.

Summit Trail Advisors first reported a position in KOD in Q2 2019 and held it in 17 quarters. The position peaked at $17.7M in Q4 2020. 101 funds tracked by Wall St. Rank hold KOD as of Q3 2023.

Summit Trail Advisors reported no remaining Kodiak Sciences position as of Q3 2023 after selling out during the quarter.
Summit Trail Advisors sold 89,308 Kodiak Sciences shares in Q3 2023, an estimated $616K.
Summit Trail Advisors first reported a position in Kodiak Sciences in Q2 2019 and held it in 17 quarters.
Summit Trail Advisors's Kodiak Sciences position peaked at $17.7M in Q4 2020.
101 funds tracked by Wall St. Rank held Kodiak Sciences as of Q3 2023.

Based on Summit Trail Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.